U.S. markets close in 1 hour 1 minute
  • S&P 500

    4,449.25
    -6.23 (-0.14%)
     
  • Dow 30

    34,905.21
    +107.21 (+0.31%)
     
  • Nasdaq

    14,981.97
    -65.73 (-0.44%)
     
  • Russell 2000

    2,292.81
    +44.74 (+1.99%)
     
  • Crude Oil

    75.27
    +1.29 (+1.74%)
     
  • Gold

    1,751.40
    -0.30 (-0.02%)
     
  • Silver

    23.74
    +1.35 (+6.02%)
     
  • EUR/USD

    1.1705
    -0.0012 (-0.11%)
     
  • 10-Yr Bond

    1.4770
    +0.0170 (+1.16%)
     
  • GBP/USD

    1.3709
    +0.0029 (+0.21%)
     
  • USD/JPY

    110.9920
    +0.3070 (+0.28%)
     
  • BTC-USD

    42,974.64
    -304.00 (-0.70%)
     
  • CMC Crypto 200

    1,064.33
    -37.19 (-3.38%)
     
  • FTSE 100

    7,063.40
    +11.92 (+0.17%)
     
  • Nikkei 225

    30,240.06
    -8.75 (-0.03%)
     

Annovis Bio Stock Crashes After Much-Hyped Alzheimer's Drug Flops In Midstage Test

·2 min read
Annovis Bio Stock Crashes After Much-Hyped Alzheimer's Drug Flops In Midstage Test
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Annovis Bio's Alzheimer's drug failed to significantly outperform the placebo in a midstage test, leading ANVS stock to plummet on Thursday.